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THE USE OF BIG DATA BY MANAGED CARE ORGANIZATIONS
Bojing Wang, Marshall University
Xiaoying Liu, Marshall University
Alberto Coustasse, Marshall University
ABSTRACT
Big data have become available in all kinds of healthcare organizations. The application of big
data analytics in Managed Care Organizations (MCOs) has the potential to improve health care,
lower costs, save lives, and help to make better-informed decisions. The study illustrated the
implication of big data in MCOs. Big data can help MCOs reduce patients’ relevance, analyze
specific diseases such as asthma and diabetes. Big data also could help MCOs to reduce cost
after collecting data and determined the specific patients’ situation. The implication of big data
has benefited MCOs in reducing costs, improving the quality of healthcare care. Interview
content, limitation, and practical implication of this study are further discussed.
Keywords: Big data, data analytics, managed care, costs, quality, diabetes, influenza,

INTRODUCTION
“Big Data” is a term used to describe massive data sets which have more varied, large
and complex structure and are not able to be stored, analyzed and visualized or cannot be
processed efficiently by traditional data management tools (Sagiroglu & Sinanc, 2013). The core
features of big data could be summarized as the five Vs., which are Volume, Variety, Velocity,
Veracity, and Value (Demchenko, Grosso, De Laat, & Membrey, 2013). Managed Care
Organizations (MCOs) have been defined as systems that integrated the financing, insurance, and
delivery of healthcare services (Ridic, Gleason, & Ridic, 2012). It was created to furnish the
health care services to covered individuals, establish selection criteria for health care providers,
create programs for processing utilization review and quality assurance, and encourage members
to use providers and procedures which were associated with their plans by financial incentives
(Shmueli, Stam, Wasem, & Trottmann, 2015). Big data have become available in all kinds of
healthcare organizations and has become necessary as deriving insights to improve healthcare
delivery and reduce waste (Sun & Reddy, 2013).
According to Konstvedt (2015), managed care has gradually replaced fee-for-service and
other traditional health care plans from 27% in 1988 to 80% in 2013. Although the rate of
managed care has started to decrease from 95% in 2003 because of the appearance of HighDeductible Health Plans with Savings Option (Konstved, 2015). Also, Preferred Provider
Organizations (PPOs) with 57% and Health Maintenance Organizations (HMOs) with 14% have
been the most prevalent types of MCOs in U.S. healthcare systems (Claxton et al., 2013).
IBM has indicated that 2.5 exabytes (1018 bytes) of data are created every day, and 90%
of the data produced in the last two years (Bhagat, 2015). In 2012, digital world of data was
expanded to 2.72 zettabytes (1021 bytes), and it would spend about 20 billion personal computers
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to store the data around the world (Sagiroglu & Sinanc, 2013). Data from U.S. healthcare
systems reached 150 exabytes in 2011, and at this rate of growth, the number would soon reach
the zettabyte (1021 gigabytes) scale, even the yottabyte (1024 gigabytes) (Cottle, Kanwal, Kohn,
Strome, & Treister, 2013).
Big data has become a trendy topic in healthcare, and the term primarily referred to the
vast and growing volumes of computerized medical information, such as drug and disease
monitoring registries, Electronic Health Records (EHRs), and administrative or health claims
data (Trifirò, Sultana, & Bate, 2017). Big data in healthcare generally has been collected through
clinical practice and administration processing by different healthcare professionals, such as
pharmacists registering prescriptions, and physicians recording the drug prescriptions, medical
history, or medical claims of their patients (Trifirò et al., 2017). The study from Futrel (2014)
predicted that the share of data for medical use would be a fourfold increase from 2012 to 2020,
but healthcare as one of the largest data producers, it has been the least prepared industries to
handle the remarkably increasing data. Also, big data has been collected without being used
which should be fully recognized by health care organizations for a long time (Trifirò et al.,
2017).
Accountable Care Organizations (ACOs) have been using big data technologies to reduce
healthcare costs and improve the quality of healthcare; in addition, ACOs have established Big
Data warehouses to optimize health care services (Tomar, Chaudhari, Bhadoria, & Deka, 2016)
A study from Frakt and Pizer (2016) have suggested that big data would rapidly improve
healthcare delivery. Big data analytics have the potential to improve health care, lower costs and
save lives, and the application of big data analytics in MCOs and ACOs could help to make
better-informed decisions (Dembosky, 2012). Driven by mandatory requirements and the
potential to improve the quality of healthcare delivery as well as reducing the costs, these
massive quantities of data hold the promise of supporting a wide range of medical and healthcare
functions, including clinical decision support, disease surveillance, and population health
management (Dembosky, 2012). Institutions and organizations might get benefits from big data
analytics for their future directions, development, decisions, investments, and challenges with
predictive as well as descriptive analytics, such as healthcare systems, user behavior analysis,
decision support systems, personalized systems, and market analysis (Sinanc, Demirezen, &
Sagiroglu, 2016).
The purpose of the research was to determine whether big data and data analytics could
reduce the costs of health care, improve the quality of care, and control overutilization within
MCOs.
METHODOLOGY
The primary hypothesis of this paper was that big data would be helpful for reducing
unnecessary health care costs and improving the quality of healthcare within MCOs. The
secondary hypothesis of this research was that big data and data analytics would play an essential
role in reducing patients' prevalence and analyzing specific disease such as diabetes for MCOs.
The methodology of this study was a literature review which could be separated into three steps:
(1) identifying literature and collecting data, (2) establishing criteria for the literature analysis
and evaluation, (3) categorizing literature. Also, a semi-structured interview has been done via
telephone for this research on March 27, 2018. Grace Sun, an expert in big data which works at a
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kidney dialysis center (Satellite Healthcare) in San Jose, California, was the person participated
in the semi-structured interview, and the interview has been recorded for the literature review.
Eight questions such as the interviewee’s work experience, facts, and opinions about big data,
and how her organization uses big data were chosen for this interview.
Step 1: Literature Identification and Data Collection
The key terms used for literature identification were “big data” OR “data analytics” AND
“managed care” OR “managed care organizations” OR “PPOs” OR “HMO” OR “health care”
AND “costs” OR “quality” OR “diabetes”, such as Academic Search Premier, PubMed,
ProQuest, ScienceDirect, and Google Scholar. Reputable websites such as the Agency for
Healthcare Research and Quality, Health Affairs, American Telemedicine Association, and CDC
were also used in the search. Citations and abstracts of articles were assessed to identify whether
they could satisfy the requirement of this study.
Step 2: Literature Analysis and Evaluation
The identified literature for the study was limited to big data and managed care. The
abstracts of academic articles and studies were reviewed first to examine the relationship of their
content with the topic. If the abstracts were found to be appropriate to the topic, the articles
would be analyzed. To stay with current trends to the topic, articles only published from 2007 to
2018 were chosen in this research. The literature evaluation and analysis were limited to the
articles which were written in the English language and full texts, and a total of 31 references
were used in this study. L.X. and W.B. did the literature search, and it was validated by A.C.
who acted as the second reader and double-checked whether all the references met the inclusion
criteria of the research study.
Step 3: Literature Categorization
After analyzing the articles, useful articles were selected and categorized into three
sections based on the findings, which included the application of big data for reducing patients’
prevalence, application of big data for analyzing special diseases, and application of big data for
reducing healthcare costs
RESULTS
The application of big data can help MCOs improve their service quality and reduce costs
by analyzing specific disease and high-risk people. Meanwhile, big data can help MCOs to
decrease rates of patients' prevalence. The primary studies showing the application of big data in
MCOs were classified by the purpose and the outcomes and summarized in Table 1 (Table 1).
Application of Big Data for Reducing Patients’ Prevalence
In the report from Grohskopf et al. (2016), big data was used to preventing influenza.
According to the data collected by ACIP from more than 30,000 patients, the vaccine HD-IIV3
seemed to be efficient to adults elder than 65 years old; and RIV4 was more effective compared
to IIV4. According to a study of the effectiveness of RIV4 and IIV4 from 2014 to 2015, 4,303
patients accepted RIV4 and 4,301 patients accepted IIV4, the result showed RIV4 was 36%
effective and IIV4 was 4% effective. In another study from 2009 to 2010 in 6,107 patients with
HD-IIV3 and 3,051 patients with vaccine SD-IIV3, this kind of vaccine was not effective against
patients elder than 65 suffered from pdm09 (Grohskopf et al., 2016). Since viruses such as
A/Michigan/45/2015 (H1N1) pdm09–like virus should be included in the vaccines from 2017 to
2018, FluMist Quadrivalent (LAIV4; MedImmune, Maryland) should not be applied in 2017 and
2018 since this kind of vaccine seemed not effective against A(H1N1) pdm09 viruses (Table 1).
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Glanz et al. (2013) conducted a study with eight MCOs investigating the vaccination by
using big data collected from more than 400,000 children born between 2004 and 2008. The
results of this study indicated that nearly 50% of these children were under-vaccinated before 24
months. Compared to unvaccinated children, vaccinated children had a 95% lower outpatient
visit rate compared to unvaccinated children (Glanz et al., 2013). Also, by reviewing the big data
collected from more than 1,000 medical records from more than 150,000 children, the
researchers also found that most nonmedical reasons came from the parents' rejection (Glanz et
al., 2013). The results of this study showed the essentialness of children before 24 months
accepting vaccines (Table 1).
Other studies such as Hechter's study found that Hepatitis B can be effectively reduced
by using the vaccine. Less than half of the patients in more than 15,000 patients suffered from
Hepatitis B after the accepted vaccine (Hechter et al., 2014). While in Abara, Qaseem, Schillie,
McMahon, and Harris (2017) study, they use big data to give suggestions to avoid suffering from
Hepatitis B. Bayen, Jacquemot, Netscher, Agrawal, Noyce, and Bayen (2017) conducted a study
analyzing falls’ threat. According to this study carried out in a Californian memory care
organization, both fatal and nonfatal injuries may happen to people elder than 65 because of the
falls. Falls has resulted in the costs of $637.2 million for fatal falls and $31.3 billion for nonfatal
falls every year. So, avoiding falls for older adults was helpful to avoid injuries (Bayen et al.,
2017).
Application of Big Data for Analyzing Specific Diseases
Big data has played an important role recently in treating asthma (Barrett et al., 2013).
Barrett, Humblet, Hiatt, and Adler (2013) found that more than 25 million Americans were
suffering from asthma. According to a study conducted by Farber, Batsell, Silveira, Calhoun, and
Giardino (2014), the possibility of patients whose mother is a smoker to suffer asthma increased
by 95% in more than 22,000 patients. The result of this study showed tobacco had a significant
influence to increase the possibility for children to suffer asthma (Table 1). In another study
analyzing asthma, patients’ condition was better after their controlling to asthma improving from
38% to 75% in the period of study (Sickle, Maenner, Barrett, & Marcus, 2013).
Two articles from Lawrence et al. (2014) and Falen, Noblin, Russell, and Santiago (2018)
both mentioned the implication of big data in MCOs. In Lawrence's study, EHRs provided by
MCOs can offer an efficient source of data while analyzing childhood diabetes surveillance.
According to Lawrence et al. (2014), among nearly 800,000 young people, 77.2% of them were
type 1 diabetes, and 22.2% were type 2 diabetes (Table 1). In another study, EHRs could allow
monitoring or surveillance to prevent postoperatively and to reduce the numbers of postoperative
infections like superficial incisional surgical site infections and deep incisional surgical site
infections (Falen et al., 2018).
The expert in big data also illustrated the implication of big data in analyzing kidney
disease. More than 50% of patients may have symptoms such as urination changes. According
to Expert, more than 80% percent of patients who need a kidney needed to wait about four years.
She also stated that although her organization has implicated big data less than five years, big
data has helped her clinic to prevent medical errors, identify high-risk patients, reduce costs,
improve productivity, and enhance patient outcomes.

5

Application of Big Data for Reducing Healthcare Cost
The adoption of EHRs has facilitated the application of big data. Researchers have found
that EHRs and big data can offer MCOs the potential for cost savings (Bates, Saria, OhnoMachado, Shah, & Escobar, 2014; Raghupathi & Raghupathi, 2014). A predictive system based
on big data could identify practical use cases such as high-cost patients, triage, adverse events,
and diseases with the treatment influenced by multiple organ systems (Bates et al., 2014). In the
example listed by Raghupathi & Raghupathi (2014), big data was used to reduce nearly $7
billion in healthcare spending (Raghupathi & Raghupathi, 2014).
Spyropolos & Lin (2007) calculated the cost of patients with deep vein thrombosis and
pulmonary embolism. Nearly 1.5,000 patients in 30 MCOs participated in this study. The rate of
readmission for patients who were primarily diagnosed with a deep vein thrombosis or
pulmonary embolism was more than five percent. The rate of the readmission for those who were
secondly diagnosed with a deep vein thrombosis or pulmonary embolism was nearly 15% in a
year (Spyropoulos & Lin, 2007). Totally, more than 50% of all hospital readmissions for deep
vein thrombosis and nearly 60% for pulmonary embolism happened in the first 90 days after the
initial event. As for the cost, the total cost of readmission for patients with a deep vein
thrombosis was more than $2,000 staying in hospital for 7.7 to 8.7 days; the total cost of
readmission for patients with pulmonary embolism was nearly $15,000 with a staying in hospital
last for 7.4 to 7.6 days (Spyropoulos & Lin, 2007). By using these big data to analyze the
possibility of readmission for patients with deep vein thrombosis or pulmonary embolism, it was
possible for these MCOs to predict and save their cost (Table 1).
According to the expert in big data, MCOs need to use big data because it can help to
reduce the cost. MCOs had departments like marketing, administrating and other financial
officers who needed big data to help their work to become more active and productive. By
dealing with the patients' feedback, MCOs are convenient to analyze sentiments and identify
patterns. Her clinic already set a specific strategic plan towards implication of big data and big
data will help them to reduce more cost in the future. Because the more data they collect and use,
the more accurate conclusion they will have, the more proper decision they will make.
Other researchers also have used big data to analyze the cost of MCOs for some specific
diseases. Kim, Lin, Hussein, Kreilick, and Battleman (2009) of atrial fibrillation in the hospital
should be changed since it made a heavy burden on MCOs. According to Kim et al. (2009),
inpatient cost for primary atrial fibrillation more than 11 thousand dollars while outpatient costs
were $2826.78 in a year. For hospitalized patients with secondary atrial fibrillation, the total cost
was more than $6557.
Application of Big Data for predicting mortality
Another important application of big data is in predicting mortality (Schneeweiss, 2014).
The method of collecting the amount of data and applied it to predict patients' outcomes has
already existed years ago. According to some articles in the past, severity of illness (SOI), Acute
Physiology and Chronic Health Evaluation (APACHE), and Simplified Acute Physiology Score
were all the examples of collecting data and implementing it (Knaus, Zimmerman, Wagner,
Draper, & Lawrence, 1981; Le Gall, Loirat, & Alperovitch, 1983). However, instead of relying
on static models manually collecting from patient datasets, collecting personalized information in
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big health data from electronic medical records (EMRs) and other monitoring devices seemed
more helpful in predicting patients’ outcome (Lee, Maslove, & Dubin, 2015).
Lee, Maslove, and Dubin (2015) conducted a study to measure the relationship between
predictive performance and the number of patients collected in the data. According to their study,
which based on 29.149 adults at the Beth Israel Deaconess Medical Center (BIDMC) in Boston,
the predictive performance increased with the increasing of patients but declined after the peak
point. By calculating the area under the receiver operating characteristic curve (ROC) and the
area under the precision-recall curve (PRC), the peak was achieved while the data collected from
6,000 patients were used (the most significant area under ROC was 0.83, and the larges area
under PRC was 0.47). After that point, these two characters were declined while the number of
patients was increasing (Lee et al., 2015). They concluded that the mortality prediction
performance would be better if big data collected from similar patients rather than a more
significant number of patients were used.
In another study conducted to measure the predictive mortality performance in hospital
emergency department, there were more than 4,000 visits in the derivation group, and 5% of
these patients died during hospitalization; while in the validation group, 4.7% of 1,056 patients
died (Taylor et al., 2016). The area under the curve (AUC) was used to measure the mortality
predictive performance. Compared to traditional methods, random forest model performed best
with a 0.860 AUC, while MEDS score got 0.705, REMS score got 0.717, and CART model got
the smallest area under the curve with the number of 0.693 (Taylor et al., 2016). As a result, the
random forest model driven by big data performed better than other traditional analytic models in
predicting in-hospital mortality (Taylor et al., 2016).
Researchers in other countries also found that big data can help to predict mortality. In
Spain, some researcher concerned older adults’ mortality with big data (Pinzon et al., 2016).
They analyzed 142,028 women and 58,011 men, whose average age was 80 years. They found
that women’s death risk is 38% less than men; nursing home care increased mortality more than
a half compared to home-based care. Meanwhile, the activities of the daily living level, age, and
chronic obstructive would also influence the risk of death.
Table 1: The Summarize of Articles on Big Data Application in Managed Care Organizations
Application
of Big Data
The
effectiveness
of the
vaccine

Author/Ye
ar
Glanz et al.
(2013)

Design
aim
⚫

Key Findings
⚫
⚫
⚫
⚫

Grohskopf
et al.
(2016)

⚫

⚫
⚫

The vaccine was effective for children before two
years’ old
Most common reason for unvaccinated children
was parent’s rejection
Nearly 50% of 400,00 children were undervaccinated before 24 months
Vaccinated children had a 95% lower outpatient
visit rate compared to unvaccinated children
RIV4 was 36% effectiveness, and IIV4 was 4%
effectiveness in totally 8.600 patients
Pregnant women should accept the specific
vaccine
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⚫
⚫
Analyzing
diseases

Farber et
al. (2014)

⚫

⚫
⚫

Reducing
cost

Lawrence
et al.
(2014)
Spyropolos
& Lin
(2007)

⚫

⚫

⚫

⚫
⚫
⚫
⚫

Kim et al.
(2009)

⚫

⚫
⚫
⚫

RIV4 was more effective than IIV4 for people
older than 65 in treating H1N1.
Vaccines in treating A/Michigan/45/2015 (H1N1)
pdm09 should be included from 2017 to 2018
the possibility of patients whose mother is a
smoker to suffer asthma increased by 95% in
more than 22,000 patients
tobacco could increase the possibility for children
to suffer asthma
77.2% of young people were type 1 diabetes, and
22.2% were type 2 diabetes in nearly 800
thousand young people
Patients diagnosed with a deep vein thrombosis or
pulmonary embolism were more than five percent
in 1.5 thousand patients
The rate of the readmission for patients secondly
diagnosed with a deep vein thrombosis or
pulmonary embolism was nearly 15% in a year
The extra cost caused by readmission was nearly
$15,000 with a staying in hospital last for 7.4 to
7.6 days
Totally, more than 50% of all hospital
readmissions for deep vein thrombosis and nearly
60% for pulmonary embolism happened in the
first 90 days after the initial event.
Big data could help MCOs organizations in
substantial saving.
Inpatient cost for primary atrial fibrillation was
more than 11,000 dollars, and outpatient costs
were $2826.78 per year.
For hospitalized patients with secondary atrial
fibrillation, the total cost was more than $6557.

DISCUSSION
This article proposed to state and clarified the implication of big data in MCOs. The
hypothesizes of this paper can be divided into two parts: big data would be helpful to reduce
unnecessary health care costs and improve the quality of healthcare within MCOs, and big data
and data analytics would play an essential role in reducing patients' prevalence and analyzing
specific disease such as diabetes for MCOs.
The results of this paper can be concluded into four parts. The results of the interview
showed that big data was useful in MCOs in helping reduce patients’ prevalence, analyzing
specific disease, and reducing cost. The literature review showed that big data could be helpful in
reducing patients' prevalence, analyzing specific disease, and reducing healthcare costs.
The expert in big data (2018) stated that the opinions that satellite healthcare in California
has applied big data for less than five years, and big data did help to their jobs by collecting data
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and analyzing the kidney disease such as kidney’s symptoms. She held the view that there might
be some limitations in applying big data since the collection of data may be limited, but big data
would be used frequently and meaningfully in the future.
However, without the right information technology infrastructure, workflows, analytic
tools, and visualization approaches, the insights provided by big data might be limited (Roski,
Bo-Linn, & Andrews, 2014). To guarantee the application of big data by MCOs, many current
practices and policies related to data use, access, sharing, privacy, and stewardship need to be
revised.
Study limitation
This literature review was limited since the limitation of the search strategy used, such as
the number of articles searched, the number of databases available. Meanwhile, the publication
and the researcher bias may have influenced the quality and the opinions of these articles.
Furthermore, although the studies and articles used in this article are concerned about the use of
big data in MCOs, not many studies described the process of big data’s collection, which
resulted in the lack of description of data collecting in this article. Last, the interviewer worked
in a kidney dialysis center, which made the expert focusing more on the implication of big data
in kidney disease.
Practical Implication
Big data has the potential to create significant value in healthcare (Lee & Yoon, 2017).
The benefits of using big data by MCOs are improving the quality of healthcare, analyzing some
chronic diseases, and reducing unnecessary healthcare costs as well as the patients’ prevalence.
Also, MCOs might make a better decision by big data analytics because they can review the
results of big data analytics more directly and immediately.
CONCLUSION
Big data has been widely implemented in MCOs, and the main three advantages of using
big data within MCOs were reducing patients' prevalence, analyzing specific diseases, and
reduce the organization's cost.
Expert in big data. (2018). Grace Sun, Satellite Healthcare, personal communication.
March 26, 2018.
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